Novartis Stock

Invest in stocks with eToro from 50 EUR

Detail	Data
Volume (24h):	2,164,435 shares
P/E Ratio:	19.56
Forward P/E:	15.70
EPS:	5.83 CHF
Forward EPS:	7.2624006 CHF
Number of Shares:	1,918,792,119 shares
Market Capitalization:	220,764,700,672.00 CHF

The interactive chart displays the price movement of Novartis shares and updates every 15 minutes. It shows both the current price and historical trends. The chart offers various time frames, including daily, weekly, or monthly views, as well as the entire trading history.

Disclaimer: The data provided is for informational purposes only. Despite our efforts to ensure accuracy, it may contain errors or be outdated. We strongly recommend verifying the data from other independent sources. No investment decisions should be made based on this information.

Dividend

The company Novartis pays a dividend of 3.5 CHF per share. The annual dividend yield is 3.07%. The average dividend yield over the last 5 years is 3.65%. The payout ratio is 54.35%. The last paid dividend was 3.5 CHF, paid on 2025-03-11. The ex-dividend date, the date when shares trade without entitlement to the next dividend, is 2025-03-11.

Dividend	Value
Dividend Amount	The company Novartis pays a dividend of 3.5 CHF per share.
Annual Yield %:	3.07 %
Ex-dividend Date:	2025-03-11
5-Year Avg Yield %:	3.65 %
Payout Ratio:	54.35 %
Last Dividend Value:	3.5 CHF
Last Dividend Date:	2025-03-11

Analyst Forecast

Most analysts have issued a hold recommendation for Novartis stock. The current number of analysts covering this company is 19. The highest target price is 126.49334 CHF, while the lowest target price is 87.28208 CHF. The median target valuation set by analysts is 110.69639 CHF. These forecasts and recommendations provide insight into how analysts view the future stock performance of Novartis.

Analysts	Recommendation
Issued Recommendation:	According to our data, the recommendation for Novartis stock is: hold
Number of Analysts:	19
Highest Target Price:	126.49334 CHF
Lowest Target Price:	87.28208 CHF
Median Target Price:	110.69639 CHF

Fundamental Indicators

Indicator	Data
Total Revenue:	56,371,998,720.00 CHF
Net Income:	14,392,999,936.00 CHF
Price-to-Book (P/B):	6.17
PEG Ratio:	/
Exchange:	Swiss
Industry:	Drug Manufacturers - General
Sector:	Healthcare
Number of Employees:	75883
Country:	Switzerland

Where to Buy Novartis Stock?

You can purchase Novartis stock on the Swiss under the ticker symbol: NOVN.SW. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

*To verify the availability of specific stocks on the platform, it's a good idea to first open a free demo account. Not all stocks are available.

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5

Invest in Stocks with eToro

★★★★★ 5.0

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5

Try Free Demo Account

★★★★☆ 4.8

Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on Novartis Stock

Indicator	Value
Company Revenue:	56,371,998,720.00 CHF
EBITDA:	24,923,000,832.00 CHF - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization.
Earnings Per Share:	5.83 CHF
Book Value Per Share:	18.47 CHF
Total Cash:	9,667,999,744.00 CHF
Total Cash per Share:	5.04 CHF
Total Debt:	32,021,999,616.00 CHF
Debt to Equity Ratio:	0.72
Quick Ratio	0.58
Current Ratio	0.88
Free Cash Flow	16,009,124,864.00 CHF
Operating Cash Flow	21,073,000,448.00 CHF
Gross Margins	76.25 %
EBITDA Margins	44.21 %
Operating Margins	31.93 %
Profit Margins	25.53 %
Return on Assets	12.1 %
Return on Equity	32.6 %
Earnings Growth (1 year)	28.7%
Revenue Growth (1 year)	9.0 %
Quarterly Earnings Year-over-Year Growth	23.2 %
Market Capitalization	220,764,700,672.00 CHF
Enterprise Value	241,595,056,128.00 CHF
EV/Revenue	4.286
EV/EBITDA	9.694
Float Shares	1,826,824,413 shares
Shares Outstanding	1,918,792,119 shares
Held Percent Insiders	0.00 %
Held Percent Institutions	41.39 %
Shares Short	-
Shares Short Prior Month	-
Date Short Interest	-
Short Percentage of Total Shares	-
Short Ratio	-
Beta	0.45
Short Percentage of Float	-
Implied Shares Outstanding	1,935,853,189

Frequently Asked Questions (FAQ)

1️⃣ Does Novartis pay dividends?

The company Novartis pays a dividend of 3.5 CHF per share. At this rate, the annual yield is 3.07 %.

2️⃣ Where to buy Novartis shares?

Novartis shares are traded on the Swiss stock exchange under the ticker: NOVN.SW. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

3️⃣ What is the forecast for Novartis shares?

According to our data, the recommendation for Novartis shares is from a total of 19 analysts. The average target price prediction is 110.69639 CHF per share.

4️⃣ What is the total number of shares and the value of Novartis on the stock exchange?

The total number of Novartis shares on the exchange is 1,918,792,119.00 shares, which at the current market capitalization gives the company a total valuation of 220,764,700,672.00 CHF.